scispace - formally typeset
D

David Rouquié

Researcher at Bayer

Publications -  27
Citations -  1519

David Rouquié is an academic researcher from Bayer. The author has contributed to research in topics: Flutamide & Toxicity. The author has an hindex of 13, co-authored 25 publications receiving 1266 citations. Previous affiliations of David Rouquié include Utrecht University & University of Tübingen.

Papers
More filters
Journal ArticleDOI

Polar PIN localization directs auxin flow in plants.

TL;DR: Interfering with sequence-embedded polarity signals directly demonstrates that PIN polarity is a primary factor in determining the direction of auxin flow in meristematic tissues.
Journal ArticleDOI

De novo generation of hit-like molecules from gene expression signatures using artificial intelligence

TL;DR: A generative model that bridges systems biology and molecular design, conditioning a generative adversarial network with transcriptomic data that can automatically design molecules that have a high probability to induce a desired transcriptomic profile.
Journal ArticleDOI

Liver tumor formation in female rat induced by fluopyram is mediated by CAR/PXR nuclear receptor activation.

TL;DR: Fluopyram is a threshold carcinogen and the resultant hepatocellular carcinomas in the female rat are due to hepato cellular proliferation mediated by CAR/PXR activation.
Journal ArticleDOI

Thyroid tumor formation in the male mouse induced by fluopyram is mediated by activation of hepatic CAR/PXR nuclear receptors.

TL;DR: Fluopyram thyroid toxicity is mediated by activation of hepatic Car/Pxr receptors and shows a threshold dependent MOA, which leads to hyperplasia and eventually adenomas after chronic exposure.